Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

ImpediMed Limited IPDQF

Set alert

Price alert · IPDQF

All alert types
0.00 USD 0.00 0.00%

At close · Oct 30

0.0039 Day range 0.004
0.002 52-week range 0.026
YTD
-82.27%
1 year
-66.95%
Open
0.004
Prev close
0.0039
Mkt cap
14.30M
Vol
160.00K
Avg vol
25.32K
EPS
-0.01
P/E
0.00
More statistics
Low
0.0039
High
0.004

3M chart

Chart tools
Interval
1m5m15m30m

Signals (18)
NameDateAgo
RSI: OversoldOct 20, 20261 week ago
SMA: BearishOct 2, 20261 month ago
MACD: Sell SignalOct 2, 20261 month ago
SMA: BullishSep 11, 20261 month ago
SMA: BullishSep 11, 20261 month ago
MACD: Buy SignalSep 11, 20261 month ago
SMA: BearishSep 10, 20261 month ago
MACD: Sell SignalSep 8, 20261 month ago
SMA: BearishSep 3, 20262 months ago
SMA: BullishSep 2, 20262 months ago
SMA: BullishSep 2, 20262 months ago
SMA: BearishSep 1, 20262 months ago
SMA: BearishSep 1, 20262 months ago
SMA: BullishAug 27, 20262 months ago
SMA: BullishAug 27, 20262 months ago
SMA: BearishAug 21, 20262 months ago
SMA: BullishAug 14, 20262 months ago
MACD: Buy SignalAug 12, 20262 months ago

Financial health

Altman Z-Score

-15.42 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 4

Valuation

P/E -0.6×
FY 2017: -10.5×FY 2018: -6.1×FY 2019: -1.9×FY 2020: -1.9×FY 2021: -5.9×FY 2022: -6.3×FY 2023: -16.5×FY 2024: -9.7×FY 2025: -4.4×FY 2026: -0.6×
FY 2017 5y median -6.3× FY 2026
P/S 1.1×
FY 2017: 50.4×FY 2018: 34.8×FY 2019: 11.2×FY 2020: 7.1×FY 2021: 14.7×FY 2022: 11.9×FY 2023: 29.8×FY 2024: 19.2×FY 2025: 8.0×FY 2026: 1.1×
FY 2017 5y median 11.9× FY 2026
P/B 1.5×
FY 2017: 4.9×FY 2018: 4.6×FY 2019: 2.9×FY 2020: 1.5×FY 2021: 4.8×FY 2022: 2.4×FY 2023: 5.5×FY 2024: 4.7×FY 2025: 4.9×FY 2026: 1.5×
FY 2017 5y median 4.7× FY 2026
P/FCF -0.8×
FY 2017: -11.2×FY 2018: -6.8×FY 2019: -2.1×FY 2020: -1.9×FY 2021: -7.8×FY 2022: -6.0×FY 2023: -14.0×FY 2024: -9.2×FY 2025: -6.5×FY 2026: -0.8×
FY 2017 5y median -6.5× FY 2026
EV/EBITDA -0.0×
FY 2017: -7.7×FY 2018: -4.5×FY 2019: -1.3×FY 2020: -0.9×FY 2021: -4.8×FY 2022: -4.5×FY 2023: -14.3×FY 2024: -7.7×FY 2025: -5.3×FY 2026: -0.0×
FY 2017 5y median -5.3× FY 2026
EV/Sales 0.0×
FY 2017: 40.9×FY 2018: 28.2×FY 2019: 8.5×FY 2020: 3.8×FY 2021: 12.4×FY 2022: 8.0×FY 2023: 25.9×FY 2024: 16.9×FY 2025: 7.4×FY 2026: 0.0×
FY 2017 5y median 8.0× FY 2026
FCF Yield -130.2%
FY 2017: -8.9%FY 2018: -14.8%FY 2019: -47.3%FY 2020: -52.8%FY 2021: -12.8%FY 2022: -16.7%FY 2023: -7.1%FY 2024: -10.8%FY 2025: -15.4%FY 2026: -130.2%
FY 2017 5y median -15.4% FY 2026

Profitability

Gross Margin -81.4%
FY 2017: 74.2%FY 2018: 66.7%FY 2019: 69.4%FY 2020: 70.5%FY 2021: 80.8%FY 2022: 83.7%FY 2023: -120.4%FY 2024: 86.9%FY 2025: 86.3%FY 2026: -81.4%
FY 2017 5y median 83.7% FY 2026
Operating Margin -151.3%
FY 2017: -533.6%FY 2018: -638.7%FY 2019: -659.2%FY 2020: -448.8%FY 2021: -276.2%FY 2022: -205.2%FY 2023: -201.4%FY 2024: -241.8%FY 2025: -190.4%FY 2026: -151.3%
FY 2017 5y median -201.4% FY 2026
Net Margin -170.4%
FY 2017: -478.2%FY 2018: -566.5%FY 2019: -588.7%FY 2020: -375.4%FY 2021: -247.9%FY 2022: -189.4%FY 2023: -180.9%FY 2024: -196.9%FY 2025: -182.6%FY 2026: -170.4%
FY 2017 5y median -182.6% FY 2026
ROE -244.5%
FY 2017: -46.9%FY 2018: -75.5%FY 2019: -152.8%FY 2020: -78.1%FY 2021: -81.2%FY 2022: -38.9%FY 2023: -33.7%FY 2024: -48.6%FY 2025: -113.4%FY 2026: -244.5%
FY 2017 5y median -48.6% FY 2026
ROIC -73.3%
FY 2017: -52.3%FY 2018: -84.9%FY 2019: -169.7%FY 2020: -90.2%FY 2021: -87.4%FY 2022: -41.7%FY 2023: -33.6%FY 2024: -57.0%FY 2025: -66.8%FY 2026: -73.3%
FY 2017 5y median -57.0% FY 2026
ROA -71.9%
FY 2017: -42.9%FY 2018: -65.1%FY 2019: -106.8%FY 2020: -64.7%FY 2021: -60.5%FY 2022: -33.9%FY 2023: -29.9%FY 2024: -42.1%FY 2025: -55.8%FY 2026: -71.9%
FY 2017 5y median -42.1% FY 2026

Growth (YoY)

Revenue 14.7%
FY 2017: -0.4%FY 2018: -16.8%FY 2019: -14.6%FY 2020: 38.9%FY 2021: 46.7%FY 2022: 25.6%FY 2023: 8.1%FY 2024: -11.4%FY 2025: 26.6%FY 2026: 14.7%
FY 2017 FY 2026
Operating Income 8.9%
FY 2017: -17.5%FY 2018: 0.4%FY 2019: 11.8%FY 2020: 5.4%FY 2021: 9.7%FY 2022: 6.7%FY 2023: -6.1%FY 2024: -6.4%FY 2025: 0.3%FY 2026: 8.9%
FY 2017 FY 2026
EPS (diluted) -1.7%
FY 2017: 9.4%FY 2018: 2.0%FY 2019: 11.8%FY 2020: 40.9%FY 2021: 52.1%FY 2022: 31.4%FY 2023: 3.4%FY 2024: 14.0%FY 2025: -17.3%FY 2026: -1.7%
FY 2017 FY 2026
Free Cash Flow -28.4%
FY 2017: -15.1%FY 2018: 4.8%FY 2019: 11.6%FY 2020: 2.0%FY 2021: 26.5%FY 2022: -32.9%FY 2023: -15.4%FY 2024: 13.3%FY 2025: 25.2%FY 2026: -28.4%
FY 2017 FY 2026

Financial Health

Current Ratio 3.8×
FY 2017: 11.2×FY 2018: 6.7×FY 2019: 2.5×FY 2020: 5.0×FY 2021: 3.2×FY 2022: 6.4×FY 2023: 8.9×FY 2024: 6.3×FY 2025: 4.9×FY 2026: 3.8×
FY 2017 5y median 6.3× FY 2026
Quick Ratio 3.5×
FY 2017: 10.9×FY 2018: 6.4×FY 2019: 2.4×FY 2020: 4.8×FY 2021: 3.1×FY 2022: 6.3×FY 2023: 8.7×FY 2024: 6.2×FY 2025: 4.7×FY 2026: 3.5×
FY 2017 5y median 6.2× FY 2026
Debt / Equity 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.7×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
Net Debt / EBITDA 0.7×
FY 2017: 1.8×FY 2018: 1.0×FY 2019: 0.4×FY 2020: 0.8×FY 2021: 0.9×FY 2022: 2.2×FY 2023: 2.2×FY 2024: 1.1×FY 2025: 0.4×FY 2026: 0.7×
FY 2017 5y median 1.1× FY 2026
Interest Coverage -5.9×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: -444×FY 2022: -769×FY 2023: -672×FY 2024: -261×FY 2025: -22.1×FY 2026: -5.9×
FY 2017 5y median -261× FY 2026

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026

Annual · latest fiscal year ends 2026-06-30